These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16599603)

  • 41. Synthesis of new artemisinin analogues from artemisinic acid modified at C-3 and C-13 and their antimalarial activity.
    Han J; Lee JG; Min SS; Park SH; Angerhofer CK; Cordell GA; Kim SU
    J Nat Prod; 2001 Sep; 64(9):1201-5. PubMed ID: 11575956
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Probing the possible molecular origin of the highly selective toxicity of antimalarial peroxide qinghaosu (artemisinin).
    Wu Y; Liu HH
    Chem Res Toxicol; 2003 Oct; 16(10):1202-6. PubMed ID: 14565761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle.
    Li Y; Shan F; Wu JM; Wu GS; Ding J; Xiao D; Yang WY; Atassi G; Léonce S; Caignard DH; Renard P
    Bioorg Med Chem Lett; 2001 Jan; 11(1):5-8. PubMed ID: 11140731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modeling the decomposition mechanism of artemisinin.
    Moles P; Oliva M; Safont VS
    J Phys Chem A; 2006 Jun; 110(22):7144-58. PubMed ID: 16737265
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantum chemical analysis of alternative pathways for iron activation step for artemisinin, a new antimalarial drug.
    Wiwanitkit V
    J Infect; 2006 Sep; 53(3):148-51. PubMed ID: 16386306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure-activity relationships of the antimalarial agent artemisinin. 6. The development of predictive in vitro potency models using CoMFA and HQSAR methodologies.
    Avery MA; Alvim-Gaston M; Rodrigues CR; Barreiro EJ; Cohen FE; Sabnis YA; Woolfrey JR
    J Med Chem; 2002 Jan; 45(2):292-303. PubMed ID: 11784134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NMR studies on novel antitumor drug candidates, deoxoartemisinin and carboxypropyldeoxoartemisinin.
    Lee CH; Hong H; Shin J; Jung M; Shin I; Yoon J; Lee W
    Biochem Biophys Res Commun; 2000 Aug; 274(2):359-69. PubMed ID: 10913344
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Orally active esters of dihydroartemisinin: Synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in mice.
    Singh C; Chaudhary S; Puri SK
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1436-41. PubMed ID: 18206370
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Syntheses and antimalarial activities of N-substituted 11-azaartemisinins.
    Torok DS; Ziffer H; Meshnick SR; Pan XQ; Ager A
    J Med Chem; 1995 Dec; 38(26):5045-50. PubMed ID: 8544181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and antimalarial activity of some 9-substituted artemisinin derivatives.
    Acton N; Karle JM; Miller RE
    J Med Chem; 1993 Aug; 36(17):2552-7. PubMed ID: 8355254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The reaction of artemisinins with hemoglobin: a unified picture.
    Messori L; Gabbiani C; Casini A; Siragusa M; Vincieri FF; Bilia AR
    Bioorg Med Chem; 2006 May; 14(9):2972-7. PubMed ID: 16412643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rh-catalyzed C-C cleavage of benzyl/allylic alcohols to produce benzyl/allylic amines or other alcohols by nucleophilic addition of intermediate rhodacycles to aldehydes and imines.
    Zhang XS; Li Y; Li H; Chen K; Lei ZQ; Shi ZJ
    Chemistry; 2012 Dec; 18(50):16214-25. PubMed ID: 23080063
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlation of antimalarial activity of artemisinin derivatives with binding affinity with ferroprotoporphyrin IX.
    Paitayatat S; Tarnchompoo B; Thebtaranonth Y; Yuthavong Y
    J Med Chem; 1997 Feb; 40(5):633-8. PubMed ID: 9057849
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antimalarial activity of new dihydroartemisinin derivatives. 7. 4-(p-substituted phenyl)-4(R or S)-[10(alpha or beta)-dihydroartemisininoxy]butyric acids.
    Lin AJ; Zikry AB; Kyle DE
    J Med Chem; 1997 Apr; 40(9):1396-400. PubMed ID: 9135037
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel ferrocenic artemisinin derivatives: synthesis, in vitro antimalarial activity and affinity of binding with ferroprotoporphyrin IX.
    Delhaes L; Blot C; Berry L; Maciejewski LA; Camus D; Brocard JS; Dive D
    Bioorg Med Chem; 2000 Dec; 8(12):2739-45. PubMed ID: 11131165
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stereoselective synthesis and antimalarial activity of alpha-artelinic acid from artemisinin.
    Vishwakarma RA; Mehrotra R; Tripathi R; Dutta GP
    J Nat Prod; 1992 Aug; 55(8):1142-4. PubMed ID: 1431937
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanism-based development of new antimalarials: synthesis of derivatives of artemisinin attached to iron chelators.
    Kamchonwongpaisan S; Paitayatat S; Thebtaranonth Y; Wilairat P; Yuthavong Y
    J Med Chem; 1995 Jun; 38(13):2311-6. PubMed ID: 7608896
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How might qinghaosu (artemisinin) and related compounds kill the intraerythrocytic malaria parasite? A chemist's view.
    Wu Y
    Acc Chem Res; 2002 May; 35(5):255-9. PubMed ID: 12020162
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Case for Development of 11-Aza-artemisinins for Malaria.
    Harmse R; Wong HN; Smit F; Haynes RK; N'Da DD
    Curr Med Chem; 2015; 22(31):3607-30. PubMed ID: 26219389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.